A real-world study on the clinicopathological profile, treatment outcomes and health-related quality of life, anxiety and depression among patients with desmoid tumor at two tertiary care centers in India
BackgroundThe medical management of DT comprises tyrosine kinase inhibitors (TKIs), hormonal agents, anti-inflammatory drugs with the recently approved gamma secretase inhibitor nirogacestat being the current standard of care. Real-world data on evolving treatment landscapes of DT remains scarce.Met...
Saved in:
| Main Authors: | Ghazal Tansir, Aparna Sharma, Bivas Biswas, Suryadev Narayan Sah, Somnath Roy, S. V. S. Deo, Sandeep Agarwala, Shah Alam Khan, Sameer Bakhshi, Deepam Pushpam |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-10-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1382856/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Desmoid-type fibromatosis tumor in children: A narrative review of the literature
by: Mohammed Awadh Bin-Salah, et al.
Published: (2025-01-01) -
Cryotherapy in the Treatment of Extra-Abdominal Desmoid Tumors—A Review
by: Kadhim Taqi, et al.
Published: (2025-02-01) -
Management of desmoid-type fibromatosis involving peripheral nerves
by: Mario G. Siqueira, et al.
Published: (2012-07-01) -
Clinical and Radiologic Outcomes after Cryoablation of Desmoid Tumors
by: Brad Bergin, et al.
Published: (2024-12-01) -
Desmoid Fibromatosis of the Triceps and Sternocleidomastoid-A Report of Two Cases
by: Shenbaghavalli Thanikaimalai, et al.
Published: (2025-07-01)